These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10786931)

  • 41. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
    Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
    J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid gastric emptying of a liquid meal in long-term Type 2 diabetes mellitus.
    Weytjens C; Keymeulen B; Van Haleweyn C; Somers G; Bossuyt A
    Diabet Med; 1998 Dec; 15(12):1022-7. PubMed ID: 9868975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M; Kishikawa H; Ohkubo Y; Wake N
    Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors.
    Valensi P; Giroux C; Seeboth-Ghalayini B; Attali JR
    J Diabetes Complications; 1997; 11(1):27-34. PubMed ID: 9025010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes.
    Jun JE; Jin SM; Baek J; Oh S; Hur KY; Lee MS; Lee MK; Kim JH
    Cardiovasc Diabetol; 2015 Jun; 14():70. PubMed ID: 26041130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM.
    Kishimoto M; Yamasaki Y; Kubota M; Arai K; Morishima T; Kawamori R; Kamada T
    Diabetes Care; 1995 Aug; 18(8):1156-9. PubMed ID: 7587851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurable deficit of autonomic and sensory nerve function in asymptomatic diabetic patients.
    Piaggesi A; Castro Lòpez E; Bini L; Benzi L; Giampietro O; Schipani E; Navalesi R
    J Diabetes Complications; 1992; 6(3):157-62. PubMed ID: 1472740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.
    McFarlane SI; Chaiken RL; Hirsch S; Harrington P; Lebovitz HE; Banerji MA
    Diabet Med; 2001 Jan; 18(1):10-6. PubMed ID: 11168335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes.
    Torlone E; Britta M; Rambotti AM; Perriello G; Santeusanio F; Brunetti P; Bolli GB
    Diabetes Care; 1993 Oct; 16(10):1347-55. PubMed ID: 8269792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of glycemic control on heart rate variability in type I diabetic patients with cardiac autonomic neuropathy.
    Burger AJ; Weinrauch LA; D'Elia JA; Aronson D
    Am J Cardiol; 1999 Sep; 84(6):687-91. PubMed ID: 10498140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.
    Ozmen B; Boyvada S
    J Diabetes Complications; 2003; 17(3):128-34. PubMed ID: 12738396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibrinolysis and diabetic retinopathy in NIDDM.
    Mansfield MW; Grant PJ
    Diabetes Care; 1995 Dec; 18(12):1577-81. PubMed ID: 8722054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Occurrence of late specific complications in type II (non-insulin-dependent) diabetes mellitus.
    Wirta OR; Pasternack AI; Oksa HH; Mustonen JT; Koivula TA; Helin HJ; Lähde YE
    J Diabetes Complications; 1995; 9(3):177-85. PubMed ID: 7548982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Continuous glucose monitoring adds information beyond HbA1c in well-controlled diabetes patients with early cardiovascular autonomic neuropathy.
    Fleischer J; Laugesen E; Cichosz SL; Hoeyem P; Dejgaard TF; Poulsen PL; Tarnow L; Hansen TK
    J Diabetes Complications; 2017 Sep; 31(9):1389-1393. PubMed ID: 28728915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood ketone bodies in NIDDM: relationship with diabetic control and endogenous insulin secretion.
    Suzuki M; Kosegawa I; Miura S; Negishi K; Itabashi A; Katayama S; Ishii J; Kamata S; Fujita C
    Diabetes Res; 1991 Sep; 18(1):11-7. PubMed ID: 1823641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood pressure and cardiac autonomic nervous system in obese type 2 diabetic patients: effect of metformin administration.
    Manzella D; Grella R; Esposito K; Giugliano D; Barbagallo M; Paolisso G
    Am J Hypertens; 2004 Mar; 17(3):223-7. PubMed ID: 15001195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between impaired cardiovascular autonomic function and hypoglycemia in patients with type 1 diabetes.
    Jaiswal M; McKeon K; Comment N; Henderson J; Swanson S; Plunkett C; Nelson P; Pop-Busui R
    Diabetes Care; 2014 Sep; 37(9):2616-21. PubMed ID: 24973438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improvement of glycemic control by 1 year of insulin therapy leads to a sustained decrease in sE-selectin concentrations in type 2 diabetes.
    Ryysy L; Yki-Järvinen H
    Diabetes Care; 2001 Mar; 24(3):549-54. PubMed ID: 11289483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.